EPFL researchers have developed a type of peptides that can enter cells and block protein interactions considered difficult to target with drugs.

Many diseases are driven by proteins interacting with each other inside cells. But blocking these interactions with drugs is difficult because typical "small-molecule" drugs often…

EPFL researchers have developed a type of peptides that can enter cells and block protein interactions considered difficult to target with drugs.

Une équipe de l'EPFL a mis au point un type de peptides capables de pénétrer dans les cellules et de bloquer des interactions protéiques connues pour être difficiles à cibler par…